Walleye Trading
BHVN

Walleye Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Walleye Trading’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-181,200
Closed -$27.4M – 5857
2022
Q3 		$27.4M Buy
181,200
+174,300
+2,526% +$25.8M 0.08% 227
2022
Q2 		$1M Buy
+6,900
New +$881K ﹤0.01% 2221
2021
Q3 		– Sell
-200
Closed -$19K – 6140
2021
Q2 		$19K Buy
+200
New +$16.2K ﹤0.01% 4869
2019
Q3 		– Sell
-100
Closed -$4K – 4752
2019
Q2 		$4K Sell
100
-15,900
-99% -$896K ﹤0.01% 3918
2019
Q1 		$824K Sell
16,000
-30,000
-65% -$1.3M 0.01% 1833
2018
Q4 		$1.7M Buy
+46,000
New +$1.66M 0.01% 1200

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Walleye Trading's BHVN Position: Q3 2022 in Review

Walleye Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 3,046 shares — an estimated $451K sold.

Walleye Trading first reported a position in BHVN in Q1 2019 and held it in 5 quarters. The position peaked at $635K in Q1 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Walleye Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 3,046 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $451K.
  • Walleye Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and held it in 5 quarters.
  • Walleye Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $635K in Q1 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.